Previously, hyperhomocysteinemia accelerates AKI to CKD progression by downregulating heme oxygenase-1 (HO-1) expression [18]; consistently, the HO-1 levels were reduced by Hcy treatment in IR mice (Figure 3C). This evidence concerns the gene HMOX1 and chronic kidney disease.